SCHEMBL6233013

SCHEMBL6233013

CCCC/C=C/C1CCC(=O)O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.46
CA1 P00915 1/20 0.37
CA9 Q16790 1/20 0.37
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
HDAC1 Q13547 4/20 0.37
HDAC8 Q9BY41 3/20 0.37
HDAC6 Q9UBN7 3/20 0.37
HDAC3 O15379 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC9 Q9UKV0 2/20 0.37
NCOR2 Q9Y618 2/20 0.37
CCR6 P51684 1/20 0.36
PRKCA P17252 3/20 0.35
FAAH O00519 1/20 0.33
MGLL Q99685 1/20 0.33
PTGER4 P35408 1/20 0.31
PTGER2 P43116 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233018 1.00 CYP1A2 (0.46) CYP1A2CA1CA9ALDH1A1TSHR
SCHEMBL142178 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL142179 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL592977 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL2597366 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL5148278 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL4444802 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL11551895 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL21409889 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8
SCHEMBL5148270 0.94 CYP1A2 (0.51) CYP1A2ALDH1A1TSHRHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120091758-A Arthropod control composition 弗门尼舍有限公司 2025-06-03 CN disclosed
US-6939845-B2 Fragrance precursors GIVAUDAN SA (CH) 2005-09-06 US disclosed
CN-1205199-C Perfume parent GIVAUDAN SA (CH) 2005-06-08 CN disclosed
EP-1167362-B1 Fragance precursors GIVAUDAN SA (CH) 2005-05-25 EP disclosed
US-20020035055-A1 Fragrance precursors GIVAUDAN SA (CH) 2002-03-21 US disclosed
CN-1330070-A Perfume parent GIVAUDAN SA (CH) 2002-01-09 CN disclosed
EP-1167362-A1 Fragance precursors Givaudan SA (CH) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035055-A1 Fragrance precursors FAAH2, FDPS, CYP51A1 CYP1A2 27/4885CA1 1806/4885CA9 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.